drugset / Trial / NCT05837338

Treatment of Post-Punch Biopsy Bleeding in Anticoagulated Patients Using Self-Administered BXP154

NCT05837338 ↗

Phase 2 Completed 24 enrolled Bio 54, LLC
RandomizedCrossoverDouble-blindTreatment

Summary

The goal of this clinical trial is to test if the study drug, BXP154 works to stop bleeding from a minor wound in patients that are on anticoagulant therapy. The main questions it aims to answer are: * How long does it take to stop bleeding after BXP154 is applied to a wound? * How many people require the use of a rescue treatment to stop bleeding? * Does BXP154 reduce instances of re-bleeding after the bleeding has stopped initially? * Is BXP154 safe and well-tolerated?

Timeline

Start
2023-05-01
Primary completion
2023-07-26
Completion
2023-07-26

Drugs

EvaluationDrugModalityDoseRoute
Subject BXP154 Unknown 1500 mg Topical